CD38 Knockout Primary NK Cells to Prevent "Fratricide" and Boost Daratumumab Activity
Author(s) -
Yuya Nagai,
Meisam Naeimi Kararoudi,
Ezgi Elmas,
Marcelo de Souza Fernandes Pereira,
Syed Abbas Ali,
Philip Imus,
Dean A. Lee,
Gabriel Ghiaur
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-129456
Subject(s) - daratumumab , antibody dependent cell mediated cytotoxicity , cd38 , cancer research , immunology , biology , cytotoxicity , cd46 , cd59 , antibody , monoclonal antibody , microbiology and biotechnology , stem cell , complement system , in vitro , biochemistry , cd34
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom